Mallet Maxime, Haq Maela, Tripon Simona, Bernard Maguy, Benosman Hedi, Thabut Dominique, Rudler Marika
aIntensive Care Unit, Department of Hepatology and Gastroenterology bDepartment of biochemistry, Groupe Hospitalier Pitié-Salpêtrière Charles Foix, Assistance Publique-Hôpitaux de Paris, Paris, France.
Eur J Gastroenterol Hepatol. 2017 Jul;29(7):811-816. doi: 10.1097/MEG.0000000000000862.
The aim of this study was to evaluate the accuracy of procalcitonin (PCT) in predicting bacterial infection and survival without transplantation upon admission in the ICU for acute liver failure (ALF).
From January 2009 until October 2015, all cases of ALF patients admitted in our ICU were retrospectively reviewed and included in the study if the PCT level upon admission was available. Patients with pre-existing liver pathology or ALF in a context of already advanced multiorgan failure were excluded. The main clinical and biological characteristics of patients were recorded, as well as the etiology of ALF, diagnosis of bacterial infection (bacteriologically documented or suspected), and outcome.
35 patients were included: 46% men, mean age 42 years, initial prothrombin ratio 31%, PCT 9.8 mg/l (0.7-49), and PCT more than 2 mg/l in 54% of cases. Etiology was acetaminophen intoxication in 18/35 (51%) cases. Sepsis was diagnosed in 9/35 (26%) cases, most frequently pneumonia with 4/9 cases. Survival without liver transplantation (LT) was observed in 28 (80%) cases. The median PCT was not different in patients with or without bacterial infection [6.3 mg/l (0.6-16) vs. 1.2 mg/l (0.8-9.7), P=0.8]. The median PCT was not different in patients who survived without LT [7.1 mg/l (0.9-16.1) vs. 0.75 mg/l (7.7-11.5), P=0.06]. In patients with ALF unrelated to acetaminophen intoxication, the median PCT was higher in patients with bacterial infection [1.1 mg/l (0.9-4) vs. 0.5 mg/l (0.3-0.8), P=0.01], but was similar in patients who did not survive without LT [0.7 mg/l (0.4-1.1) vs. 0.8 mg/l (0.4-2.2), P=0.6]. In the overall cohort, the median C-reactive protein (CRP) and leukocyte count were higher in patients who developed bacterial infection [40 mg/l (19-60) vs. 16 mg/l (6-34), P=0.04; 11.9 G/l (8.3-19) vs. 7.9 G/l (6-12.6), P=0.05]. The median CRP and leukocyte count were not significantly different in survivors versus nonsurvivors without LT.
PCT was an accurate predictor for the diagnosis of bacterial infection only in patients with ALF unrelated to acetaminophen intoxication. CRP was higher in patients who developed infection and could also be an interesting tool in ALF patients.
本研究旨在评估降钙素原(PCT)在预测急性肝衰竭(ALF)患者入住重症监护病房(ICU)时细菌感染及非移植生存情况方面的准确性。
回顾性分析2009年1月至2015年10月期间入住我院ICU的所有ALF患者病例,若有入院时的PCT水平则纳入研究。排除既往有肝脏病变或处于多器官功能衰竭晚期背景下的ALF患者。记录患者的主要临床和生物学特征,以及ALF的病因、细菌感染诊断(细菌学证实或疑似)和结局。
纳入35例患者:男性占46%,平均年龄42岁,初始凝血酶原比值31%,PCT为9.8mg/L(0.7 - 49),54%的病例PCT超过2mg/L。病因方面,18/35(51%)例为对乙酰氨基酚中毒。9/35(26%)例诊断为脓毒症,最常见的是肺炎,有4/9例。28(80%)例患者实现了非肝移植生存。有或无细菌感染患者的PCT中位数无差异[6.3mg/L(0.6 - 16)对1.2mg/L(0.8 - 9.7),P = 0.8]。非肝移植生存患者的PCT中位数无差异[7.1mg/L(0.9 - 16.1)对0.75mg/L(7.7 - 11.5),P = 0.06]。在与对乙酰氨基酚中毒无关的ALF患者中,有细菌感染患者的PCT中位数更高[1.1mg/L(0.9 - 4)对0.5mg/L(0.3 - 0.8),P = 0.01],但非肝移植未生存患者的PCT中位数相似[0.7mg/L(0.4 - 1.1)对0.8mg/L(0.4 - 2.2),P = 0.6]。在整个队列中,发生细菌感染患者的C反应蛋白(CRP)中位数和白细胞计数更高[40mg/L(19 - 60)对16mg/L(6 - 34),P = 0.04;11.9G/L(8.3 - 19)对7.9G/L(6 - 12.6),P = 0.05]。非肝移植生存者与非生存者的CRP中位数和白细胞计数无显著差异。
PCT仅在与对乙酰氨基酚中毒无关的ALF患者中是细菌感染诊断的准确预测指标。发生感染的患者CRP更高,在ALF患者中也可能是一个有价值的工具。